RCT of Nintedanib in Fibrotic Sarcoidosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

RCT of Nintedanib in Fibrotic Sarcoidosis — Stella

Recruiting

Back to Sarcoidosis, Pulmonary trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

India

Postgraduate Institute of Medical Education and Research, Chandigarh

Key details

Phase

Post-approval study

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh

Enrollment target

~120 participants

Started

June 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov